Complete Response Letters

TherapeuticsMD, Inc.: estradiol

What FDA's Complete Response Letters to the company say, in the letters' own words.

EphemerisX Research · Sep 30, 2026 · Sources: FDA, SEC

Complete Response Letter, May 5, 2017

We have the following comments/recommendations that are not approvability issues but should be addressed prior to or by the time of your NDA resubmission:

Complete Response Letter · May 5, 2017 · p. 5Open the letter at p. 5 ↗CRL_NDA208564_20170505:p2:s31

More Complete Response Letters

All companies in the CRL Tracker →

Updated Sep 30, 2026 · built from 283 companies in the EphemerisX knowledge graph. This page is regenerated as companies are added.